Economic Evaluation of Changes in Reimbursement for Medications Purchased Through the 340B Drug Pricing Program
Sign Up to like & getrecommendations! Published in 2021 at "Hospital Pharmacy"
DOI: 10.1177/0018578719888907
Abstract: Background: The Centers for Medicare and Medicaid Services (CMS) implemented changes to the reimbursement scheme for 340B-acquired medications on January 1, 2018, reducing payments by approximately 25%. It was recognized that these changes would have… read more here.
Keywords: 340b drug; reimbursement; changes reimbursement; evaluation ... See more keywords
Access to the 340B Drug Pricing Program: is there evidence of strategic hospital behavior?
Sign Up to like & getrecommendations! Published in 2021 at "BMC Research Notes"
DOI: 10.1186/s13104-021-05642-4
Abstract: Objective The 340B Drug Pricing Program allows hospitals to purchase covered drugs at a discount and potentially generate profit if they are reimbursed at rates that exceed 340B acquisition prices. Disproportionate share hospitals (DSH) are… read more here.
Keywords: pricing program; drug pricing; program; 340b drug ... See more keywords